1-5 of 5
Kim-Anh Do, PhD
Close
Sort by
Journal Articles

Evolutionary Action Score Identifies a Subset of TP53 Mutated Myelodysplastic Syndrome with Favorable Prognosis

Rashmi Kanagal-Shamanna, MD, Guillermo Montalban Bravo, MD, Panagiotis Katsonis, Koji Sasaki, MD, Caleb Class, PhD, Christopher B. Benton, MD, Elias Jabbour, MD, Kelly S. Chien, MD, Rajyalakshmi Luthra, PhD, Carlos E. Bueso-Ramos, MD PhD, Tapan M. Kadia, MD, Michael Andreeff, MD PhD, Nicholas J. Short, MD, Naval Daver, MD, Mark Routbort, MD PhD, Joseph D. Khoury, MD, Keyur Patel, MD PhD, Irene Ganan-Gomez, PhD, Yue Wei, PhD, Gautam Borthakur, MD, Farhad Ravandi, MBBS, Kim-Anh Do, PhD, Kelly A. Soltysiak, PhD, Olivier Lichtarge, L. Jeffrey Medeiros, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-141411
Published: 2020
Journal Articles

Impact of Hemoglobin Level As a Continuous Variable in Calculating Prognosis in MDS: Incorporation into LSC4 and IPSS-R

Faezeh Darbaniyan, PhD, Guillermo Montalban Bravo, MD, Yue Wei, PhD, Rashmi Kanagal-Shamanna, MD, Koji Sasaki, MD, Hui Yang, MD PhD, Kelly A. Soltysiak, PhD, Kelly S. Chien, MD, Kim-Anh Do, PhD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-140029
Published: 2020
Journal Articles

Transcriptomic Analysis Implicates Necroptosis in Disease Progression and Prognosis in Myelodysplastic Syndromes

Guillermo Montalban-Bravo, MD, Caleb Class, PhD, Irene Ganan-Gomez, PhD, Rashmi Kanagal-Shamanna, MD, Koji Sasaki, MD, Guillaume Richard-Carpentier, MD, Kiran Naqvi, MDMPH, Yue Wei, PhD, Hui Yang, PhDMD, Kelly Soltysiak, PhD, Kelly S. Chien, MD, Carlos E. Bueso-Ramos, MD PhD, Kim-Anh Do, PhD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3006.
https://doi.org/10.1182/blood-2019-124957
Published: 2019
Journal Articles

Evolutionary Action (EA) Score of TP53 Mutations Defines Prognostic Subsets within TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia

Rashmi Kanagal-Shamanna, MD, Guillermo Montalban-Bravo, MD, Caleb Class, PhD, Koji Sasaki, MD, Christopher B. Benton, MD, Kelly Soltysiak, PhD, Elias Jabbour, MD, Tapan M. Kadia, MD, Carlos E. Bueso-Ramos, MD PhD, Keyur P. Patel, MBBS, PhD, Mark Routbort, MD PhD, Irene Ganan-Gomez, PhD, Yue Wei, PhD, Gautam M. Borthakur, MD, Farhad Ravandi, MD, Kim-Anh Do, PhD, L. Jeffrey Medeiros, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1719.
https://doi.org/10.1182/blood-2019-130545
Published: 2019
Journal Articles

The Effect of Initial Therapy Choice in Determining Long Term Survival in Patients with Chronic Lymphocytic Leukemia (CLL).

Constantine S. Tam, MBBS, Sijin Wen, MS MA, Kim-Anh Do, PhD, Susan Lerner, MS, William G. Wierda, MD PhD, Susan O’Brien, MD, Michael J. Keating, MBBS
Journal: Blood
Blood (2006) 108 (11): 4976.
https://doi.org/10.1182/blood.V108.11.4976.4976
Published: 2006